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Background: One in four Australian births are induced. If cervical ripening using a prostaglandin is required, a
pre-labour overnight hospitalisation and separation from family and support companions is necessary. Recent
evidence shows that balloon catheter cervical ripening is just as effective as prostaglandins, but does not cause
uterine stimulation. For women with low risk pregnancies, this offers the possibility of undergoing the overnight
ripening process in their own home. We conducted a pilot randomised trial to assess the outcomes, clinical
pathways and acceptability to both women and clinicians of outpatient balloon catheter ripening compared with
usual inpatient care.
Methods: Forty-eight women with low risk term pregnancies were randomised (2:1) to either outpatient (n = 33) or
inpatient double-balloon catheter (n = 15) cervical ripening. Although not powered for statistically significant
differences, the study explored potential direction of effect for key clinical outcomes such as oxytocin use, caesarean
section and morbidities. Feedback on acceptability was sought from women at catheter insertion and 4 weeks after
the birth, and from midwives and doctors, at the end of the study.
Results: Clinical and perinatal outcomes were similar. Most women required oxytocin (77 %). The outpatient group
were 24 % less likely to require oxytocin (risk difference −23.6 %, 95 % CI −43.8 to −3.5). There were no failed
inductions, infections or uterine hyperstimulation attributable to the catheter in either group. Most women in both
groups reported discomfort with insertion and wearing the catheter, but were equally satisfied with their care and
felt the baby was safe (91 % both groups). Outpatient women reported feeling less isolated or emotionally alone.
Most midwives and doctors (n = 90) agreed that they are more comfortable in sending home a woman with a
catheter than prostaglandins and 90 % supported offering outpatient ripening to eligible women.
Conclusions: Outpatient balloon catheter ripening should be further investigated as an option for women in an
adequately powered randomised trial.
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Induction of labour is undertaken in about a quarter
(26 %) of all births in Australia, with the main reasons
being for prolonged pregnancy or psychosocial reasons
[1]. For women who have an unfavourable cervix for
labour induction, the induction process often begins
with a pharmacological cervical ripening agent such as
prostaglandin E2. These preparations are convenient to
use and quick acting in bringing about cervical ripening.
However, they are costly, involve a pre-labour overnight
hospitalization and can have undesirable side effects for
both mother and baby, particularly from hyperstimula-
tion. An alternative is the mechanical method of trans-
cervical balloon catheter ripening, a technique that was
first used decades ago and has recently experienced an
international resurgence as a method that is efficacious,
has fewer side effects, and may be less costly than
pharmaceutical methods. Recent studies have validated
the use of balloon catheters and found them to be
equally effective and safe as pharmacological methods,
with the advantage of not causing hyperstimulation and
unfavourable cardiotocograph (CTG) changes [2–4].
Most balloon catheter ripening is done as an overnight
hospitalisation along the same protocols as pharmaco-
logical methods. However the lack of direct myometrial
stimulation may reduce the need for close and continu-
ous monitoring of mother and baby in a hospital envir-
onment and existing evidence suggests that that balloon
catheters may have a role in the outpatient setting. A
trial of 111 women published in 2001 comparing single
balloon catheter outpatient ripening with inpatient single
balloon catheter ripening foundthe outpatient approach
to be just as effective, with no difference in clinical out-
comes or adverse events [5]. A Cochrane review of out-
patient induction of labour concluded that outpatient
induction is feasible and that important adverse events
are rare. In addition, it concluded that there was insuffi-
cient evidence to know which induction methods are
preferred by women, or which interventions are the
most effective and safe to use in outpatient settings [6].
In 2008–11 we conducted an outpatient ripening trial,
the OPRA Study, with 827 low risk women comparing
outpatient and inpatient cervical ripening with prosta-
glandin E2. We found no significant differences in
maternal or neonatal outcomes [7], and improved psy-
chosocial outcomes [8]. Women preferred outpatient
care and did not experience additional anxiety upon ran-
domisation to the outpatient group. Economic evalu-
ation was favourable for outpatient care [9], and the
practice was supported by midwives [10]. However, we
did find that because of uterine stimulation or non-
reassuring fetal monitoring following prostaglandin ad-
ministration, less than half of the women who intended
to go home overnight actually went home or remainedhome overnight. Thus, planning to discharge women for
a night’s rest after prostaglandin cervical ripening does
not achieve that aim for the majority of women. We also
found that pregnancy complications (hyperstimulation
and hypoxaemic ischaemic encephalopathy) were more
than expected for a low risk population for both in-
patient and outpatient prostaglandins ripening.
Our experience with the OPRA Trial found that al-
though the practice of outpatient ripening was sup-
ported, prostaglandins might not be the best vehicle by
which to achieve this. Subsequently, we conducted an
exploratory pilot trial to explore the need for a larger
randomized controlled trial with balloon catheter ripen-
ing. The objectives of this pilot were to (1) To compare
key labour and birth outcomes in inpatient compared
with outpatient catheter ripening for direction of effect
and magnitude (2) To assess the clinical pathways of the
intervention and determine the acceptability from the
perspective of both pregnant women and health care
providers.
Methods
We conducted a pilot randomized controlled trial at
the largest maternity teaching hospital (Women’s and
Children’s Hospital) in Adelaide, South Australia, be-
tween October 2012 to July 2013, after obtaining
approval from the Womens and Childrens Health Net-
work Human Research Ethics Committee (REC2453/3/
15). A designated research midwife, not involved in pa-
tient care, recruited eligible women scheduled for in-
duction who were attending public clinics or the birth
centre. Written, informed consent was obtained and
documented. Randomisation was delayed until just
after the catheter was inserted, so that women rando-
mised to an intervention were most likely to receive
that intervention. Eligible women were randomized to
either staying in hospital or to go home for cervical
ripening with a double-balloon cervical ripening cath-
eter (Cooks® Cervical Ripening Balloon J-CRBS-184000).
Eligibility criteria included: term (37–42 weeks), healthy
pregnancy; intact membranes and bishop score of < 7;
singleton, cephalic presentation and appropriately grown;
cervical ripening being done for reasons other than fetal
or maternal compromise (i.e., low risk, post dates and so-
cial inductions, excluding previous caesarean sections).
Randomization and analysis
Randomization was stratified for parity and a 2:1 (out-
patient to inpatient) ratio was used in order to maximize
our experience with outpatient management. A computer-
generated list with randomly allocated block sizes was pre-
pared and sequentially numbered. Allocation assignments
were placed and sealed in opaque envelopes by a person
not otherwise involved in the conduct of the trial and
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curred. Envelopes were only opened after participant de-
tails were recorded.
The pilot study was not powered to determine statis-
tically significant differences in clinical or psychosocial
outcomes, but to determine potential direction and mag-
nitude of effect. Analysis was by intention to treat and data
analysis was performed with SPSS and EpiInfo [11, 12]. As
this was a pilot study, analysis was primarily descriptive
and differences focused on confidence interval estimations
[13]. Clinical and system data were directly collected and
entered into a computer database by the designated re-
search midwife. Data were independently cross-checked
and reviewed for accuracy.
Acceptability of the alternative priming processes was
measured at catheter insertion and four weeks after de-
livery. Immediately following catheter insertion women
were asked to indicate on a visual analogue scale the
degree of discomfort they felt by marking on a 10 cm
line, with zero at the far left of the scale (no discomfort)
to 10 cm at the far right (extreme discomfort). Four
weeks after the birth, a de-identified questionnaire simi-
lar to the validated instrument used in the OPRA trial
was mailed to women, with a two week follow-up for
non-responders. The questionnaire sought information
on satisfaction with care, preparedness, the induction
environment and specific items relating to the catheter
ripening process. Responses were organized in a 5-point
Likert scale response format. Two additional free text re-
sponse questions asked women their feelings on having
the catheter in place and positive and negative aspects of
this method.Cervical ripening protocol
Eligible participants presented to hospital in the after-
noon for ripening and underwent 20 min of pre-catheter
CTG monitoring. Following satisfactory monitoring, a
clinician (doctor or midwife trained to insert the cath-
eter) inserted a double balloon catheter and inflated each
balloon with 70–80 mls of sterile water in the Women’s
Assessment Service (the hospital’s emergency department).
Women were subsequently randomized to inpatient or
outpatient care and CTG monitoring was maintained for a
minimum of 20 min post insertion.
Those randomized to outpatient care were discharged
home following satisfactory CTG monitoring with writ-
ten instructions and a direct telephone number to the
senior midwife on duty in the Women’s Assessment
Department. The woman was requested to remain at
home and to return to the labour ward at 08.00 the fol-
lowing morning or earlier in the event of onset of labour,
rupture of membranes, vaginal bleeding or other compli-
cations or concerns. Women remained at home until thefollowing morning in the absence of labour onset or if
the catheter fell out.
The pathway for both inpatient and outpatient women
was the same the following morning; An amniotomy
was performed, followed by an oxytocin infusion if
labour did not begin within 4 h, in accordance with the
South Australian Perinatal Practice Guidelines on induc-





Catheter priming was a novel intervention at the investi-
gating institution. Orientation seminars were conducted
prior to the study and individual training given by senior
staff as needed. In order to determine clinicians’ views of
this new method, an anonymous questionnaire was dis-
tributed to both doctors and midwives who were in-
volved in the ripening process at the conclusion of the
pilot study. The questionnaire sought information on
the clinical experience and opinions of the catheter in a
5-point Likert scale response format. The questions were
modelled on survey instruments used by the authors in
similar published work [10]. Additional questions were
formatted as free text responses exploring opinions of
catheter ripening and views of what should be consid-
ered for outpatient ripening to be a sustainable practice.
Results
A total of 141 women were assessed for eligibility, of
whom a large proportion spontaneously laboured before
the scheduled induction. Of the remaining potentially
eligible 63 women, fifteen (24 %) declined to participate.
Three women were not randomized due to catheter as-
sociated issues: clinician unable to insert catheter, spon-
taneous rupture of membranes on balloon inflation, and
fetal heart rate deceleration noted at insertion. All three
were admitted and managed without complications. This
left 48 women who were randomized into the study; 33
outpatients and 15 inpatients (Fig. 1).
Clinical outcomes
The characteristics of the two groups were similar with
the primary reason (90 %) for induction of labour being
post-dates or to avoid prolonged pregnancy (Table 1).
The labour and delivery outcomes for the two groups
were also similar (Table 2). Most women required oxy-
tocin (77 %) either for induction or augmentation of
labour. Women who had outpatient ripening were about
24 % less likely to require oxytocin (risk difference of
−23.6 %, 95 % CI −43.8 to −3.5) and had a lower caesar-
ean section rate, although this was not statistically sig-
nificant (risk difference of −15.1 %, 95 % CI −42.4 to
Fig. 1 Recruitment and randomization into COPRA study. *1 change her mind & remained in hospital, 1 small bleed after insertion, 1 unsatisfactory
CTG during post-insertion monitoring
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tions or uterine hyperstimulation attributed to the
ripening catheter. Six nulliparous women (12.5 %) in
the study also required a single dose of PGE2 gels as
amniotomy was not possible after catheter removal. Half
of these women eventually required a caesarean section.
The overall caesarean section rate was 23 %, a rate simi-
lar to that of women (25 %) who received PGE2 ripening
in our recently published outpatient prostaglandin Trial
(OPRA) [7].
There were no serious maternal or neonatal morbid-
ities attributed to catheter ripening, as per Table 3. One
baby, delivered by caesarean section for fetal distress and
failure to progress 14 h post readmission after outpatient
priming, was admitted to intensive care following meco-
nium aspiration syndrome. The baby was discharged
from hospital in good condition after 17 days. Three
babies, (one randomized to inpatient and two to out-
patient) were noted as being febrile or given antibiotics.
These were individually reviewed and complete blood
count and blood cultures showed no lymphocytosis or
definitive evidence of infection.
Clinical pathway
Catheter insertion (with or without using a speculum)
varied according to the clinician’s preference; most were
done with a speculum (Table 1). There were 7 minor
catheter related occurrences in the 48 women such as
vaso-vagal reaction to insertion or altered sensation
while voiding. In all cases the issue resolved without
complications and the catheters remained in situ over-
night. There were two cases of hyperstimulation in the
study. Both occurred while an oxytocin infusion was
being used and were not attributed to the catheter.
Of the 33 women randomized to outpatient care, three
did not go home overnight (Fig. 1). For the 30 outpatient
women who were discharged home overnight, only two
returned before planned admission the following morn-
ing; one returned due to anxiety, the other due to onsetof contractions. Catheters fell out spontaneously in 29 %
(14/48) of all women either at home or in the hospital
and were more likely to fall out in multiparous women
(67 % 8/12) than in nulliparous women (17 % 6/36).
Outpatient women spent an average of 12.3 h out of
hospital after having the catheter inserted.Acceptability of the catheter to women
Visual analogue pain scores (0-100 mm) at catheter
insertion were obtained on all but two women (96 % re-
sponse rate). Women scored pain with the digital tech-
nique (without using a speculum) only slightly lower
(mean score 26.7, std 19.9) than with the speculum tech-
nique (mean score 28.9 std 24.7).
The response rate on the 4 week postnatal question-
naire was 67 % in the outpatient group and 73 % in the
inpatient group (overall response rate of 69 %, 33/48).
The majority of women (70 %) agreed or strongly agreed
with the statement “The insertion of the catheter was
physically uncomfortable”. Likewise, most women (58 %)
agreed that they were physically uncomfortable while
waiting for the catheter to work, with just over half
(51 %) also agreeing that the wearing of the catheter was
physically uncomfortable. More outpatient women re-
ported being physically uncomfortable while waiting for
ripening to work (68 %) than inpatient women (36 %).
Women who experienced outpatient ripening were
less likely to report feeling isolated (9 % compared with
30 % of inpatients) or feeling emotionally alone (9 % vs.
36 % inpatients) during the ripening process. All out-
patient women reporting that they had enough privacy
during ripening (compared with only 54 % of inpa-
tients). None of the outpatient women reporting being
in noisy surroundings (compared with 27 % inpatients).
Most women reported being able to start labour in a
peaceful environment (91 % outpatients, 73 % inpa-
tients). Outpatient women in general (70 %) did not
have concerns about how long to remain at home. One
Table 1 COPRA characteristics (n = 48)
Characteristica Inpatient
N = 15 (%)
Outpatient
N = 33 (%)
Parity
Nulliparous 11 (73.3) 25 (75.7)
Parous 4 (26.6) 8 (24.2)
Mean (SD) age 29.1 (6.8) 28.9 (4.2)
Marital status
Married/Defacto 12 (80.0) 32 (96.8)
Single 3 (20.0) 1 (3.1)
Language spoken at home
English only 13 (86.7) 24 (75.0)
Other language 2 (13.3) 8 (25.0)
Education
University degree 5 (35.7) 17 (53.1)
Post-high school training 6 (42.9) 11 (34.4)
High school only 3 (21.4) 4 (12.5)
Reason for induction
Prolonged pregnancy 13 (86.7) 26 (78.8)
To avoid prolonged pregnancy - 4 (12.1)
Social - 1 (3.0)
Otherb 2 (13.3) 2 (6.1)
Gestation at priming Median
weeks+ days (IQR)
40+8 (40+5- 40+10) 40+7 (40+6- 40+10)
Modified Bishop’sscore
0–2 5 (33.3) 8 (25.8)
3–4 9 (60.0) 16 (51.6)
≥5 1 (6.6) 7 (22.6)
Mean (SD) time waiting for catheter
insertion (range 15 mins to 5 h)
1 h 36 mins
(1 h 09 mins)
2 h 02 mins
(1 h 21 mins)
Mean (SD) time waiting for catheter
to discharge from Women’s
Assessment service
2 h 55 mins
(1 h 02 mins)
3 h 02 mins
(1 h 26 mins)
Catheter insertion technique
Speculum 13 (92.9) 25 (78.1)
Digital 1 (7.1) 7 (21.9)
Mean (SD) pain score insertion
(scale 0–100 visual analogue scale)
25.1 (20.3) 31.1 (24.8)
Catheter removal
Spontaneously fell out in hospital 2c (13.3) 1d (3.0)
Spontaneously fell out at home n/a 11e (33.3)
Clinician removed 13 (86.7) 21 (63.6)
Mean (SD) time catheter in situ
(removed by clinician)
14 h 48 min
(4 h 5 min)
14 h 32 min
(2 h 22 min)
Mean (SD) time catheter
spontaneous fell out
6 h 35 mins
(5 h 18 mins)
10 h 50 min
(4 h 13 mins)
Table 1 COPRA characteristics (n = 48) (Continued)
Mean (SD) length of time
at home with catheter
n/a 12 h 27 mins
(2 h 50 mins)
Outpatient women return to
hospital before scheduled
n/a 2 (6.7 %)f
Catheters spontaneously fell out in 29.2 % of all women (14/48), in 66.7 % of
all parous women (8/12), and in 16.7 % of all nulliparous women (6/36)
n = 1 contraction onset, returned 3:45 am
aMaximum amount of not stated for any variable n=2 (Bishop score, VAS pain
score, insertion technique)
bOther reasons= back pain, previous term stillbirth, previous large baby
cBoth women were multiparous
dWoman was primiparous
en=6 women were multiparous
fBased on n=30 discharged home. Reason for return; n=1 anxious, returned
10 pm
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hospital in time.
Most women (75 %) did not report a good nights rest
with the catheter, although this was more common as an
inpatient (91 %) than as an outpatient (68 %). Qualitative
responses suggested many women were uncomfortable
with the catheter overnight, particularly when toileting,
but were pleased with results in the morning. Many of
the outpatient women positively commented on the op-
portunity to go home and be in their own environment.
Overall, women in both groups were equally satisfied
with the care they received for their ripening and felt the
baby was safe (91 % both groups). Approximately half of
women in both groups (50 % outpatient, 45 % inpatients)
agreed that they would recommend this method to others,
with about a third unsure and the remaining 20 % not
recommending this method of ripening.Acceptability of the catheter to clinicians
A total of 90 clinician questionnaires were returned
(response rate of 56 % from midwives and 59 % from
doctors). Over the course of the study, only seven (11 %)
of midwives surveyed had inserted a balloon catheter for
ripening. Of the doctors, 64 % had inserted a balloon
catheter, mostly medical officers and registrars.
Scheduling and availability of staff to insert catheters
was viewed as problematic by the majority of midwives
(67 %) and doctors (52 %). However in terms of clinical
efficacy and choice, the majority of doctors and mid-
wives agreed or strongly agreed with the following state-
ments; catheters have advantages over PGEs in cervical
ripening (68 % midwives, 92 % doctors), I am more
comfortable sending home a woman overnight with a
catheter than PGEs (67 % midwives, 72 % doctors) and
eligible women should be given the option of catheter
outpatient ripening (89 % midwives, 92 % doctors). The
invasiveness of balloon catheters was considered a major
disadvantage over PGE2 gels by approximately half of all
Table 2 COPRA labor and delivery outcomes (N = 48)
Variable Inpatient N = 15 (%) Outpatient N = 33 (%) Risk difference (95 % CI)
Rupture of Membranes
Spontaneous 0 4 (12.1)a -
Artificial Rupture of Membranes 15 (100) 30 (90.9)b
Oxytocin Infusion 14 (93.3) 23 (69.7) −23.6 % (−43.8 to −3.5)
Reason for oxytocin infusion
Induction oflabor 8 (57.1) 14 (60.9)
Augmentation 6 (42.8) 9 (39.1)
Duration of oxytocin infusion 5 h 9 mins 7 h 47 mins
Mean (SDminutes) (3 h 51 mins) (4 h 59 mins)
PGE2 given in addition to catheter
(ie not ARMable after removal, 1 dose only)
2 (13.3) 4 (12.1)
Method of delivery
Spontaneous vaginal 7 (46.7) 16 (48.5) Overall LSCS rate 22.9 %
Instrumental 3 (20.0) 11 (33.3) −15.1 % (−42.4 to 12.1)
Caesarean section 5 (33.3) 6 (18.2) c/s
Indications for caesarean section (n = 5) (n = 6) -
Fetal distress 1 (20.0) -
Lack of progress 3 (60.0) 6 (100.0)
Other (malpresentation, etc.) 1 (20.0) -
Mean (SD) length of active labor, vaginal births (n = 10) 8 h 0 mins (6 h 54 min) (n = 27) 7 h 34 min (4 h 14 min)
Vaginal delivery within 24 h of priming catheter? 4 (26.7) 11 (33.3) -
Mean (SD) time catheter inserted to active labour
(vaginal delivery)
19 h 49 mins (3 h 3 mins) 17 h 28 mins (3 h 54 mins)
Mean (SD) time catheter inserted to ARM 17 h 39 mins (5 h 6 mins) 17 h 37 mins (3 h 38 mins)
Mean (SD) time catheter inserted to vaginal deliveryc 29 h 01 mins (8 h 5 mins) 24 h 51 mins (5 h 32 mins)
Mean (SD) hours hospital admission to deliveryc 21 h 27 mins (5 h 18 mins) 14 h 15 mins (7 h 20 mins)
Labor analgesiaepidurald 11 (73.3) 23 (69.7) -
Labor complicationse
Meconium-stained liquor 1 (6.7) 4 (12.1)
PPH >500 ml (vaginal births) or 1 L c/s 2 (13.3) 6 (18.1)
Pyrexia during labor 0 - 1 (3.0)
Hyperstimulation 1 1f
Failed primings - -g
aAll cases of spontaneous rupture of membranes occurred in hospital
bn = 1 case of spontaneous rupture of membranes, followed by ARM
cExcludes n = 1 outpatient case whose management changed & delivered spont 5 days after catheter removal
dIncludes n = 2 (1 in each group of spinal anaesthesia)
eWomen may have more than one labor complication. PPH, post-partum hemorrhage
fWoman also received PGE2 priming gels
gn = 1 change of management; women 39+3 had catheter for 12 h, high head, IOL abandoned, NVD 5 days later
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(44 %).
Free text comments were overall positive, however
system issues were frequently mentioned such as the
need for organised staff training, especially for up skil-
ling of midwives so that women were not kept waiting
for medical practitioners and the requirement for adesignated place for catheter insertions. Some midwives
felt the insertion process was traumatic for certain
women, such as those who were inexperienced with
speculum exams or were from non-English speaking
backgrounds. Midwives on the antenatal ward commen-
ted that women slept better overnight with cervical ca-
theters compared with those who had prostaglandin
Table 3 Neonatal outcomes
Characteristic Inpatient
N = 15 (%)
Outpatient
N = 33 (%)
Gender
Male 9 (60.0) 18 (54.5)
Female 6 (40.0) 15 (45.5)
Birth weight mean g, (SD) 3721 (522) 3537 (494)
Congenital anomalies 1 -
Apgar <7 at 5 min - 2a (6.1)
Admission to neonatal intensive care - 1 (3.0)
Special care nursery admissions: 7 (46.7) 12 (36.4)
Feeding problems - 1
Respiratory problems - 1
Blood sugar regulation - 1
Febrile or antibioticsb 2 1
Maternal care 2 2
Other (observation) 3 6
Length of staymean days (SD) 3.9 (1.8) 3.3c (1.3)
aOne case of meconium aspiration syndrome, baby admitted to neonatal
intensive care. The other case involved a tight nuchal cord
bComplete blood count and blood cultures showed no growth or signs of
infection in babies. In one case mother was febrile after prolonged labour,
mother afebrile in other cases
cexcludes n = 1 NICU admission for 17 days unrelated to priming
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tions overnight.
Discussion
This pilot study was designed to assess the clinical feasi-
bility and acceptability to women and caregivers of out-
patient balloon cervical ripening. Our findings suggest
that outpatient ripening with a balloon catheter may be
a viable option for appropriately screened women with
low-risk, post-date pregnancies. Women who went
home with a catheter had similar clinical outcomes to
those who remained in hospital. There were no cases of
uterine hyperstimulation or adverse outcomes associated
with the catheter in either group. Although this pilot
study was underpowered to demonstrate significant dif-
ferences, the statistically significant finding that oxytocin
use was 24 % lower in the outpatient group is of interest
and would support our supposition that that women
who went home were more relaxed and more likely to
labour spontaneously. Although the study was not
designed as a comparative analysis with prostaglandin
ripening, the clinical outcomes were similar to our recent
experience with the OPRA prostaglandin outpatient trial
[7] with the advantage that there were no cases of hyper-
stimulation attributed to catheter ripening and fewer
cases of fetal distress were seen in labour. This observa-
tion has been noted in specifically designed studies com-
paring catheter ripening with prostaglandins [3, 14, 15].A meta analysis of 27 randomised controlled trials with
3,523 women, comparing catheters with prostaglandins
revealed there was no significant difference in caesarean
section, but balloon catheter ripening requires more oxy-
tocin use [16]. The oxytocin use of 77 % in our study was
consistent with the literature and was largely used for in-
duction, rather than augmentation as would be expected
with the action of non-pharmacological ripening.
A commonly used outcome measure in cervical rip-
ening and labour induction is delivery within 24 h, al-
though the appropriateness of this has recently been
questioned [17]. In our study, only about a third of women
in the two groups delivered with 24 h, consistent with
other catheter studies [3, 4]. However, in a recent trial
comparing two time periods for Foley catheter ripening
(12 h and 24 h in situ) compared with PGE2 insert,
women in the 24 h group had a significantly longer time
to onset of labour as compared with the 12 h catheter
group, but not in the PGE2 group. Women in both cath-
eter groups had less side effects than the PGE2 group,
suggesting a better safety profile with mechanical methods
[18]. A recent large recent multicentre randomized con-
trolled trial of 824 women demonstrated that use of a
balloon catheter for ripening was just as efficacious as
prostaglandins, but resulted in fewer adverse side effects,
although with a longer time to delivery [14].
We did not follow a strict time-based protocol, but ra-
ther women were assessed for amniotomy the morning
following the ripening process that occurred overnight.
For both groups (whose catheters did not spontaneously
fall out) this averaged approximately 14.5 h of having
the catheter in situ. The ideal time period for keeping a
catheter in situ is unknown, and recommendations range
from 12–24 h, to until the catheter falls out [16, 19]. In
a recent trial comparing Foley catheters with prostaglan-
dins, catheters remained in place until expulsion or
Bishop score was favourable for amniotomy up to 48 h
[14]. A rigid time-based regime may not be in the best
interest of women. Reasons given for the goal of delivery
within 24 h of ripening (excluding high risk pregnancies)
are usually cited as maternal preference [20] and the
cost of hospitalization (which would self evidently not
be relevant in outpatient management). However the
objective of bringing about delivery within 24 h of ripen-
ing has been recently questioned [17, 21]. It is possible
that women would be willing to trade off the possibil-
ity of a longer ripening to active labour duration if
they were able to do this with comparable outcomes
or even reduced intervention (such as syntocinon use)
and avoiding additional time in hospital.
One of our primary objectives was to assess the
acceptability of the catheter to women. Unlike a digital
vaginal examination usually required to insert PGE2 gels,
a balloon catheter insertion usually involves a speculum
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from her vagina and lying between her legs during the
ripening process. In general, women found the catheter
insertion process uncomfortable, irrespective of the digital
or speculum methods, although fewer clinicians attempted
the digital method. Another study assessing the two
methods of catheter insertion found that the speculum
group had higher pain scores as measured subjectively
and objectively, however the overall satisfaction with cath-
eter ripening was high [22]. Other studies have also found
that women find the insertion uncomfortable. Henry et al.
reported women were twice as likely to feel discomfort
with the catheter insertion as compared with PGE2 gel
insertion, however once the catheter/PGEs were inserted,
they were half as likely to feel discomfort with the
catheter as compared to the PGEs [4]. Another study
found women rated on a visual analogue scale the double
balloon catheter insertion as more uncomfortable than
the single balloon, but less uncomfortable than PGE2 gel
insertion [3]. The Pennell et al. study [3] also found, as
did this study, that some women had difficulties in void-
ing when the double balloon catheter was used. However,
this problem has not been reported with the single
balloon catheter. It is possible that the different balloon
inflation volume (two 80 ml balloons in a double catheter
vs. a 30 ml balloon with a Foley catheter) contributes to
the higher degree of discomfort and is more likely to
cause urinary symptoms. The possibility of using less
volume in the vaginal balloon of the double balloon cath-
eter should be explored.
One of the hypotheses of outpatient ripening is that
women will be more relaxed and have better sleep over-
night in their home environment. It was encouraging
that all but two women who were discharged home were
able to remain at home until the following morning.
This is in sharp contrast to the nearly 40 % of women
who returned to hospital overnight with PGE2 out-
patient ripening in our recent trial, mostly due to con-
traction onset [7]. Although women in the outpatient
group reported more discomfort overnight, they also
reported being more relaxed and having better sleep
than women who were awaiting catheter ripening in
hospital. The higher reported discomfort in the out-
patient group may have been because women at home
were not offered mild analgesia (inpatient women were).
In the Henryetal. study, women reported significantly
better sleep at home with a catheter compared with
inpatient ripening with PGE2 [4]. However in this study,
both groups were offered nocturnal sedation and a mild
pain killer. In future studies involving outpatient cervical
ripening, the option of offering mild analgesia to take
home should be considered.
This was an exploratory study introducing a new para-
digm of pre induction care, so we were also interested inexploring issues that could affect caregivers. While most
women completed the catheter protocol (including pre
and post CTG monitoring) within a timely manner, a
few women had to wait up to 5 h before being seen and
discharged home. This was distressing to both women
and staff. A designated treatment room and improved
scheduling systems for catheter insertions would greatly
reduce this problem. Other systems issues noted as a
concern to staff included staff training, the availability of
a second person to assist and a setup package for cath-
eter insertion. The few cases involving clinicians unable
to insert the catheter was not unexpected as this was a
new procedure for many. Although there were too few
cases to follow over time, pain scores on insertion were
anecdotally observed to decrease as operator experience
increased. The majority of midwives and doctors agreed
that they would be more comfortable in sending home a
woman with a catheter than prostaglandins, and 90 %
supported the option of offering outpatient ripening to
eligible women. This supports our earlier finding with
the OPRA study, that midwives supported the option of
outpatient ripening [10].
Although cost were not examined, savings may be
possible with outpatient ripening, as costs will be influ-
enced by the number of overnight accommodations. In
this study, outpatient women stayed at home an average
of twelve and a half hours, and had a shorter length of
stay. Henry et al. [4] also found that women with an out-
patient catheter spent significantly less time in hospital
(approximately 11 h) prior to birth, however their overall
inpatient stay was not statistically shorter.
As a pilot investigation, the study is limited by the
small size and lack of statistical power, which makes
interpretation of small differences difficult. However, the
direction of the effect is consistent with other studies
and adds to the growing evidence pointing to balloon
catheters as being a favourable option for cervical ripen-
ing in appropriately screened women. The response rates
to questionnaires of approximately 70 % from women
and 60 % from clinicians was generally good. However it
could be that women and clinicians who did not have
favourable views were less likely to respond. Also, the
results were limited to a single metropolitan hospital,
which may affect the generalizability to other facilities.
The obligatory unblinded implementation of the inter-
vention may have introduced biases in management, but
this was reflective of the pragmatic nature of the trial.
Conclusions
Results of this pilot study were encouraging from both a
woman’s and clinician’s perspective. The study was able
to demonstrate comparable outcomes in all clinical out-
comes with the use of oxytocin being statistically signifi-
cantly reduced in women allocated to the outpatient
Wilkinson et al. BMC Pregnancy and Childbirth  (2015) 15:126 Page 9 of 9group. Clinicians supported a woman’s option for out-
patient catheter ripening and were more comfortable
sending women home with a catheter than with prosta-
glandins. The discomfort experienced by women at inser-
tion was brief, however, reducing ongoing discomfort
overnight could be investigated by offering with mild anal-
gesia as well as by altering the balloon volume used. The
catheter ripening process may be slower than pharmaco-
logical methods, but may also have better outcomes as
measured by hyperstimulation and fetal distress. The pos-
sibility of cervical ripening with catheters in an outpatient
setting should be explored in an adequately powered trial.
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